Gemphire Therapeutics
Why Robinhood?
You can watch GEMP and buy or sell other stocks, ETFs, and their options commission-free!About GEMP
Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand.
GEMP Key Statistics
Stock Snapshot
With a market cap of 18.89M, Gemphire Therapeutics(GEMP) trades at $8.18. The stock has a price-to-earnings ratio of -0.13.
During the trading day, Gemphire Therapeutics(GEMP) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Gemphire Therapeutics(GEMP) stock has reached 0, versus its average volume of 217.1K.
The stock's 52-week range extends from a low of $1.17 to a high of $23.10.
The stock's 52-week range extends from a low of $1.17 to a high of $23.10.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.